行政院衛生署,2006。成人代謝症候群之判定標準。台北。台灣。http://www.bhp.doh.gov.tw/BHPnet/Portal/AchieventShow.aspx?No=200712250031 資料於 2010 年 08 月 12 日下載。
行政院衛生署,2010。民國 98 年國人十大死因統計。台北。台灣。http://www.doh.gov.tw/CHT2006/DisplayStatisticFile.aspx?d=71700&s=1 資料於 2010 年 03 月 23 日下載。
陳佳慧,2008。利用高果糖誘發大鼠代謝症候群模式探討複方食材對代謝症候群的影響。中原大學生物科技研究所碩士論文。陳紀樺,2004。肥胖、胰島素抗性與代謝症候群。食品工業。36: 1-17。曾憲鵬,2009。高與低分子量幾丁聚醣對 streptozotocin/nicotinamide 誘發之第 2 型糖尿病大白鼠糖代謝和脂質代謝之影響。國立台灣海洋大學食品科學系碩士論文。蔡敏郎,1993。不同分子量、不同去乙醯程度的幾丁聚醣溶液的流變性質與膠囊物性的關係。國立台灣海洋大學水產食品科學研究所碩士論文。
謝侑霖,2010。幾丁聚醣影響 Streptozotocin-nicotinamide 誘發之耐糖不良大白鼠脂肪組織之研究。國立台灣海洋大學食品科學系碩士論文。簡盟月、吳英黛,2006。胰島素阻抗與運動訓練的效果—細胞與分子層面之探討。物理治療。31: 130-141.Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F. and Gordon, J. I. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101: 15718-15723.
Baxter, A., Dillon, M., Taylor, K. D. and Roberts, G. A. (1992). Improved method for i. r. determination of the degree of N-acetylation of chitosan. International Journal of Biological Macromolecules 14: 166-169.
Bays, H. E., Chapman, R. H. and Grandy, S. (2007) The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. International Journal of Clinical Practice 61: 737-747.
Berger, J. J. and Barnard, R. J. (1999) Effect of diet on fat cell size and hormone-sensitive lipase activity. Journal of Applied Physiology 87: 227-232.
Bezerra, R. M., Ueno, M., Silva, M. S., Tavares, D. Q., Carvalho, C. R. and Saad, M. J. (2000) A high fructose diet affects the early steps of insulin action in muscle and liver of rats. The Journal of Nutrition 130:1531-1535.
Bieger, W. P., Michel, G., Barwich, D., Biehl, K. and Wirth, A. (1984) Dim-inished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia. Metabolism 33: 982-987.
Bizeau, M. E. and Pagliassotti, M. J. (2005) Hepatic adaptations to sucrose and fructose. Metabolism: Clinical and Experimental 54: 1189-1201.
Blakely, S. R., Hallfrisch, J., Reiser, S. and Prather, E. S. (1981) Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. The Journal of Nutrition 111: 307-314.
Carlson, S. E. and Goldford, S. (1979) A sensitive enzymatic method of determination of free and esterified tissue cholesterol. Clinica Chimica Acta 79: 575-582.
Catena, C., Giacchetti, G., Novello, M., Colussi, G., Cavarape, A. and Sechi, L. A. (2003) Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. American Journal of Hypertension 16: 973-978.
Chong, M. F., Fielding, B. A. and Frayn, K. N. (2007) Mechanisms for the acute effect of fructose on postprandial lipemia. The American Journal of Clinical Nutrition 85: 1511-1520.
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L. and Caro, J. F. (1999) Serum immunoreactive leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 341: 879-884.
Cornier, M. A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H. and Eckel, R. H. (2008) The Metabolic Syndrome. Endocrine Reviews 29: 777-822.
Delbosc, S., Paizanis, E., Magous, R., Araiz, C., Dimo, T., Cristol, J. P., Cros, G. and Azay, J. (2005) Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179: 43-49.
Deuchi, K., Kanauchi, O., Imasato, Y. and Kobayshi, E. (1994) Decreasing effect of chitosan on the apparent fat digestibility by rats fed on a high-fat diet. Bioscience, Biotechnology, and Biochemistry 58: 1613-1616.
Faure, P., Rossini, E., Lafond, J. L., Richard, M. J., Favier, A. and Halimi, S. (1997) Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. The Journal of Nutrition 127: 103-107.
Feng, F., Liu, Y. and Hu, K. (2004) Influence of alkali-freezing treatment on the solid state structure of chitin. Carbohydrate Research 339: 2321-2324.
Folch, J., Lees, M. and Solane, G. M. (1957) A simple method for the isolation and purification of total lipids from animal tissues. The Journal of Biological Chemistry 226: 497-509.
Fruhbeck, G., Gomez-Ambrosi, J., Muruzabal, F. J. and Burrell, M. A. (2001) The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology Endocrinology and Metabolism 280: 827-847.
Furukawa, S., Fujita, T. and Shimabukuro, M. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation 114: 1752-1761.
Gallaher, D. D., Gallaher, C. M., Mahrt, G. J., Carr, T. P., Hollingshead, C. H., Hesslink, R. J. and Wise, J. A. (2002) Glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. Journal of the American College of Nutrition 21: 428-433.
Ge, H., Cha, J. Y., Gopal, H., Harp, C., Yu, X., Repa, J. J. and Li, C. (2005) Differential regulation and properties of angiopoietin-like proteins 3 and 4. The Journal of Lipid Research 46: 1484-1490.
Grundy, S. M. (2006) Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nature Reviews Drug Discovery 5: 295-309.
Havel, P. J. (2005) Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutrition Reviews 63: 133-157.
Hayashi, K. and Ito, M. (2002) Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biological and Pharmaceutical Bulletin 25: 188-192.
Hernández-González, S. O., González-Ortiz, M., Martínez-Abundis, E. and Robles-Cervantes, J. A. (2010) Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects. Nutrition Research 30: 392-395.
Hotamisligil, G. S., Arner, P., Atkinson, R. L. and Spiegelman, B. M. (1997) Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46: 451-455.
Hotamisligil, G. S., Shargill, N. S. and Spiegelman, B. M. (1993) Adipose expression of tumor necrosis factor-alpha : Direct role in obesity-linked insulin resistance. Science 259: 87-91.
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T. and Matsuzawa, Y. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 1595-1599.
Hubbard, S. R. (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. The EMBO Journal 16: 5572-5581.
Hubbard, S. R., Wei, L., Ellis, L. and Hendrickson, W. A. (1994) Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372: 746-754.
Isomaa, B., Almgren, P., Tuomi, T., Forse´n, B., Lahti, K., Nisse´n, M., Taskinen, M. R. and Groop, L. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
Jurgens, H., Haass, W., Castanedana, T. R., Schurmann, A., Koebnick, C., Dombrowski, F., Otto, B., Nawrocki, A. R., Scherer, P. E., Spranger, J., Ristow, M., Joost, H. G., Havel, P. J. and Tschop, M. H. (2005) Consuming fructose-sweetened beverages increases body adiposity in mice. Obesity Research 13: 1146-1156.
Kanauchi, O., Deuchi, K., Imasato, Y. and Kobayashi, E. (1994) Increasing effect of a chitosan amd ascorbic acid mixture on fecal dietary fat excretion. Bioscience, Biotechnology, and Biochemistry 58: 1617-1620.
Kanauchi, O., Deuchi, K., Imasato, Y., Shizukuishi, M. and Kobayashi, E. (1995) Mechanism for the inhibition of ascorbate. Bioscience, Biotechnology, and Biochemistry 59: 786-790.
Kasim-Karakas, S. E., Vriend, H., Almario, R., Chow, L. C. and Goodman, M. N. (1996) Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. The Journal of Laboratory and Clinical Medicine 128: 208-213.
Kim, I., Kim, H. G., Kim, H., Kim, H. H., Park, S. K., Uhm, C. S., Lee, Z. H. and Koh, G. Y. (2000) Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochemical Journal 346: 603-610.
Kim, I., Moon, S. O., Koh, K. N., Kim, H., Uhm, C. S., Kwak, H. J., Kim, N. G. and Koh, G. Y. (1999) Molecular cloning, expression, and characterization of angiopoietin-related protein. The Journal of Biological Chemistry 274: 26523-26528.
Knorr, D. (1984) Use of chitinous polymer in food-A challenge for food research and development. Food Technology 38: 85-97.
Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H. and Furukawa, H. (2002) Angptl3 regulates lipid metabolism in mice. Nature Genetics 30: 151-157.
Kopelman, P. G. (2000) Obesity as a medical problem. Nature 404: 635-643.
Kumar, M. N. V. R. (2000) A review of chitin and chitosan applications. Reactive and Functional Polymer 46: 1-27.
Kurita, K. (2006) Chitin and chitosan: Functional biopolymers from marine crustaceans. Marine Biotechnology 8: 203-226.
Lazar, M. A. (2005) How obesity causes diabetes: Not a tall tale. Science 307: 373-375.
Le Jan, S., Amy, C., Cazes, A., Monnot, C., Lamandé, N., Favier, J., Philippe, J., Sibony, M., Gasc, J. M., Corvol, P. and Germain, S. (2003) Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. The American Journal of Pathology 162: 1521-1528.
Liu, J., Zhang, J. and Xia, W. (2008) Hypocholesterolaemic effects ofdifferent chitosan samples in vitro and in vivo. Food Chemistry 107: 419-425.
Liu, S. H., Chang, Y. H. and Chiang, M. T. (2010) Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry 58: 5795-5800.
Maezaki, Y., Tsuji, K., Nakagawa, Y., Kawai, Y., Akinoto, M., Tsugita, T., Takekawa, W., Terada, A., Hara, H. and Mitsuoka, T. (1993) Hypocholesterolemic effect of chitosan in adult males. Bioscience, Biotechnology, and Biochemistry 57: 1439-1444.
Mandard, S., Zandbergen, F., Straten, E., Wahli, W., Kuipers, F., Muller, M. and Kersten, S. (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. The Journal of Biological Chemistry 281: 934-944.
Marriott, B. P., Cole, N. and Lee, E. (2009) National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. The Journal of Nutrition 139: 1228-12335.
Mashige, F., Tanaka, N., Maki, A., Kamei, S. and Yamanaka, M. (1981) Direct spectrophotometry of total bile acids in serum. Clinical Chemistry 27: 1352-1356.
Matsuzawa, Y., Funahashi, T. and Nakamura, T. (1999) Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Annals of the New York Academy of Sciences 892: 146-154.
Meister, A. (1988) Glutathione metabolism and its selective modification. The Journal of Biological Chemistry 263: 17205-17208.
Miura, T., Usami, M., Tsuura, Y., Ishida, H. and Seino, Y. (1995) Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. Biological and Pharmaceutical Bulletin 18: 1623-1625.
Moller, D. E. (2000) Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends in Endocrinology and Metabolism 11: 212-217.
Morimoto, C., Kameda, K., Tsujita, T. and Okuda, H. (2001) Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. Journal of Lipid Research 42: 120-127.
Müller, G., Ertl, J., Gerl, M. and Preibisch, G. (1997) Leptin impairs metabolic actions of insulin in isolated rat adipocytes. The Journal of Biological Chemistry 272: 10585-10593.
Muzzarelli, R. A. A. and Rocchetti, R. (1985) Determination of the degree of acetylation of chitosans by first derivative ultraviolet spectrophotometry. Carbohydrate Polymers 5: 461-472.
Nabel, E. G. (2003) Cardiovascular disease. The New England Journal of Medicine 349: 60-72.
Natali, A. and Ferrannini, E. (2004) Hypertension, insulin resistance, and the metabolic syndrome. Endocrinology and Metabolism Clinics of North America 33: 417-429.
Neyrinck, A. M., Bindels, L. B., Backer, F. D., Pachikian, B. D., Cani, P. D. and Delzenne, N. M. (2009) Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. International Immunopharmacology 9: 767-773.
Nyby, M. D., Abedi, K., Smutko, V., Eslami, P. and Tuck, M. L. (2007) Vascular angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertension Research 30: 451-457.
Oike, Y., Akao, M., Kubota, Y. and Suda, T. (2005) Angiopoietin-like proteins: Potential new targets for metabolic syndrome therapy. Trends in Molecular Medicine 11: 474-479.
Oike, Y., Ito, Y., Maekawa, H., Morisada, T., Kubota, Y., Akao, M., Urano, T., Yasunaga, K. and Suda, T. (2004) Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 103: 3760-3766.
Ono, M., Shimizugawa, T., Shimamura, M., Yoshida, K., Noji-Sakikawa, C., Ando, Y., Koishi, R. and Furukawa, H. (2003) Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. The Journal of Biological Chemistry 278: 41804-41809.
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Yamashita, S.,Funahashi, T. and Matsuzawa, Y. (1999) Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476.
Paolisso, G., Gambardella, A., Tagliamonte, M. R., Saccomanno, F., Salvatore, T., Gualdiero, P., D’Onofrio, M. V. F. and Howard, B. V. (1996) Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? Journal of Clinical Endocrinology and Metabolism 81: 4244-4248.
Park, Y. K. and Yetley, E. A. (1993) Intakes and food sources of fructose in the United States. The American Journal of Clinical Nutrition 58: 737-747.
Pessin, J. E. and Saltiel, A. R. (2000) Signaling pathways in insulin action: Molecular targets of insulin resistance. Journal Clinical Investigation 106: 165-169.
Qi, L., Xu, Z., Jiang, X., Hu, C. and Zou, X. (2004) Preparation and antibacterial activity of chitosan nanoparticles. Carbohydrate Research 339: 2693-2700.
Rinaudo, M. (2006) Chitin and chitosan: Properties and applications. Progress in Polymer Science 31: 603-632.
Roberts, C. K., Barnard, R. J., Liang, K. H., and Vaziri, N. D. (2002) Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: Implications for obesity and hyperlipidemia. Atherosclerosis 161: 133-141.
Roglans, N., Vila, L., Farre, M., Alegret, M., Sanchez, R. M., Vazquez-Carrera, M. and Laguna, J. C. (2007) Impairment of hepatic Stat-3 activation and reduction of PPAR alpha activity in fructose-fed rats. Hepatology 45: 778-788.
Rotter, V., Nagaev, I. and Smith, U. (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin resistant subjects. The Journal of Biological Chemistry 278: 45777-45784.
Saltiel, A. R. and Kahn, C. R. (2001) Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O´Reilly, D. S., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M. and Shepherd, J. (2003) Metabolic syndrome with and without c-reactive protein as a predictor of coronary heart disease and diabetes in the west of scotland coronary prevention study. Circulation 108: 414-419.
Segersvard, R., Rippe, C., DuPlantier, M., Herrington, M. K., Isaksson, B., Adrian, T. E. and Erlanson-albertsson, C. (2005) mRNA for pancreatic uncoupling protein 2 increases in two models of acute experimental pancreatitis in rats and mice. Cell and Tissue Research 320: 251-258.
Senn, J. J., Klover, P. J., Nowak, I. A. and Mooney, R. A. (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51: 3391-3399 .
Shimamura, M., Matsuda, M., Kobayashi, S., Ando, Y., Ono, M., Koishi, R., Furukawa, H., Makishima, M. and Shimomura, I. (2003) Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochemical and Biophysical Research Communications 301: 604-609.
Shulman, G. I. (2000) Cellular mechanisms of insulin resistance. The Journal of Clinical Investigation 106: 171-176.
Song, D., Hutchings, S. and Pang, C. C. (2005) Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. European Journal of Pharmacology 508: 205-210.
Stern, M. P., Williams, K., Gonzalez-Villapando, C., Hunt, K. J. and Haffner, S. M. (2004) Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27: 2676-2681.
Sugaya, A., Sugiyama, T., Yanase, S., Shen, X. X., Minoura, H., and Toyoda, N. (1999) Expression of glucose transporter 4 mRNA in adipose tissue and skeletal muscle of ovariectomized rats treated with sex steroid hormones. Life Science 66: 641-648.
Sukonina, V., Lookene, A., Olivecrona, T., Olivecrona, G. (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proceedings of the National Academy of Sciences of the United States of America 103: 17450-17455.
Swarbrick, M. M., Stanhope, K. L., Elliott, S. S., Graham, J. L., Krauss, R. M., Christiansen, M. P., Griffen, S. C., Keim, N. L. and Havel, P. J. (2008) Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. The British Journal of Nutrition 100: 947-952.
Takehisa, F. and Suzuki, Y. (1990) Effect of guar gum and cholestyramine on plasma lipoprotein cholesterol in rats. Journal of Japanese Society of Nutrition and Food Science 43: 269-274.
Tappy, L. and Lê, K. A. (2006) Metabolic effects of fructose. Current Opinion in Clinical Nutrition and Metabolic Care 9: 469-475.
Tappy, L. and Lê, K. A. (2010) Metabolic effects of fructose and the worldwide increase in obesity. Physiological Reviews 90: 23-46.
Tharanathan, R. N. and Harish Prashanth, K. V. (2007) Chitin/chitosan: modifications and their unlimited application potentialdan-an overview. Trends in Food Science and Technology 18: 117-131.
Tsaih, M. L. and Chen, R. H. (1999) Molecular weight determination of 83% degree of deacetylation chitosan with non-gaussian and wide range distribution by high-performance size exclusion chromatography and capillary viscometry. Journal of Applied Polymer Science 71: 1905-1913.
Tsuchida, A., Yamauchi, T. and Kadowaki, T. (2005) Nuclear receptors as targets for drug development: Molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor, CREB-Binding protein, and adiponectin. Journal of Pharmacological Sciences 97: 164-170.
Tsuchida, A., Yamauchi, T. and Kadowaki, T. (2005) Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor, CREB-Binding protein, and adiponectin. Journal of pharmacological sciences 97: 164-170.
Unger, R. H. (2003) Minireview: Weapons of lean body mass destruction:the role of ectopic lipids in the metabolic syndrome. Endocrinology 144: 5159-5165.
van de Velde, K. and Kiekens, P. (2004) Structure analysis and degree of substitution of chitin, chitosan and dibutyrylchitin by FT-IR spectroscopy and solid state 13C-NMR. Carbohydrate Polymers 58: 409-416.
Varum, K. M., Ottoy, M. H., and Smidsorod, O. (2001) Acid hydrolysis of chitosans. Carbohydrate Polymers 46: 89-98.
Walder, K., Filippis, A., Clark, S., Zimmet, P. and Collier, G. R. (1997) Leptin inhibits insulin binding in isolated rat adipocytes. Journal of Endocrinology 155: 5-7.
Wang, T., Turhan, M., and Gunasekaran, S. (2004) Selected properties of pH-sensitive, biodegradable chitosan-poly (vinyl alcohol) hydrogel. Polymer International 53: 911-918.
Wang, W., Bo, S., Li, S. and Qin, W. (1991) Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. International Journal of Biological Macromolecules 13: 281-285.
Wilson, P. D. F., D’Agostino, R. B., Parise, H., Sullivan, L. and Meigo, J. B. (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072.
Xu, A., Lam, M. C., Chan, K. W., Wang, Y., Zhang, J., Hoo, R. L. C., Xu, J. Y., Chen, B., Chow, W. S., Tso, A. W. K. and Lam, K. S. L. (2005) Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proceedings of the National Academy of Sciences 102: 6086-6091.
Xu, G., Huang, X., Qiu, L., Wu, J. and Hu, Y. (2007) Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats. Asia Pacific Journal of Clinical Nutrition 16: 313-317.
Xydakis, A. M., Case, C. C., Jones, P. H., Hoogeveen, R. C., Liu, M. Y., Smith, E. O., Nelson, K. W. and Ballantyne, C. M. (2004) Adiponectin, inflammation,and the expression of the metabolic syndrome in obese individuals: The impact of rapid weight loss through caloric restriction. The Journal of Clinical Endocrinology and Metabolism 89: 2697-2703.
Yao, H. T., Huang, S. Y. and Chiang, M. T. (2008) A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food and Chemical Toxicology 46: 1525-1534.
Yoshida, K., Shimizugawa, T., Ono, M. and Furukawa, H. (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. The Journal of Lipid Research 43: 1770-1772.
Zander, M., Madsbad, S., Madsen, J. L. and Holst, J. J. (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and [beta]-cell function in type 2 diabetes: A parallel-group study. Lancet 395: 824-830.